Favara MT, Smith J, Friedman D, Lafferty M, Carola D, Adeniyi-Jones S, Greenspan J, Aghai ZH. Growth failure in infants with neonatal abstinence syndrome in the neonatal intensive care unit.
J Perinatol 2022;
42:313-318. [PMID:
34381175 DOI:
10.1038/s41372-021-01183-7]
[Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/08/2021] [Revised: 07/10/2021] [Accepted: 07/29/2021] [Indexed: 11/09/2022]
Abstract
OBJECTIVE
To assess if infants with neonatal abstinence syndrome (NAS) are smaller at birth and have decreased growth parameters between birth and discharge from the neonatal intensive care unit (NICU).
METHODS
Retrospective data analysis of term/late-preterm neonates with NAS at a single-center NICU between September 2006 and May 2018. Growth parameters (weight, length, HC) were measured at birth and discharge. Z scores and percentiles were calculated using WHO standard growth curves.
RESULTS
A total of 864 infants ≥35 weeks were admitted for NAS. At birth, median percentiles were weight 30%, HC 23%, and length 37%; these decreased significantly (p < 0.001) at discharge to 12%, 6.5%, and 13%, respectively. The percentage of infants <3rd percentile increased significantly (p < 0.001) in all growth parameters from birth to discharge.
CONCLUSION
Infants with NAS are smaller at birth and have significant growth retardation in all growth parameters at discharge. An ongoing long-term growth follow-up study will discern the impact of growth restriction in NAS infants.
Collapse